Chloride binding by the AML1/Runx1 transcription factor studied by NMR  by Wolf-Watz, Magnus et al.
Chloride binding by the AML1/Runx1 transcription factor studied by
NMR
Magnus Wolf-Watza, Stefan Ba«ckstro«mb, Thomas Grundstro«mc, Uwe Sauerb, Torleif Ha«rda;*
aDepartment of Biotechnology, Royal Institute of Technology (KTH), Center for Structural Biochemistry, Novum, S-141 57 Huddinge, Sweden
bUCMP, Umeafi University, S-901 87 Umeafi, Sweden
cDepartment of Cell and Molecular Biology, Umeafi University, S-901 87 Umeafi, Sweden
Received 13 November 2000; accepted 29 November 2000
First published online 20 December 2000
Edited by Thomas L. James
Abstract It is known that the DNA binding Runt domain of the
AML1/Runx1 transcription factor coordinates Cl3 ions. In this
paper we have determined Cl3 binding affinities of AML1 by
35Cl nuclear magnetic resonance (NMR) linewidth analysis. The
Runt domain binds Cl3 with a dissociation constant (Kd;Cl) of 34
mM. If CBFL is added to form a 1:1 complex, the Kd;Cl value
increases to 56 mM. Homology modeling suggests that a high
occupancy Cl3 binding site overlaps with the DNA binding
surface. NMR data show that DNA displaces this Cl3 ion.
Possible biological roles of Cl3 binding are discussed based on
these findings. ß 2001 Federation of European Biochemical
Societies. Published by Elsevier Science B.V. All rights re-
served.
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1. Introduction
Runx1, also termed AML1, CBFa2 or PEBP2KB, is togeth-
er with runx2 and runx3 the mammalian members of the Runt
family of heterodimeric transcription factors. All runx pro-
teins share the Runt domain [1], a 128 amino acids long evo-
lutionary conserved segment that is responsible for both DNA
binding and heterodimerization with CBFL. CBFL acts to
stabilize the DNA-bound state of the Runt protein without
contacting DNA [2]. Both nuclear magnetic resonance (NMR)
[3] and X-ray crystallography ([4] ; Ba«ckstro«m et al., unpub-
lished) structures of the Runt domain have been determined
and they reveal that the fold is Ig like. The Runt domain
shares structural homology with the DNA binding domains
of the NFUB, NFAT, p53 and STAT families, all of which
contain the Ig fold. Runt proteins are involved in a diverse set
of biological functions and human diseases. Biological func-
tions in mammals that are dependent on Runt proteins are for
instance osteogenesis [5] and de¢nitive hematopoiesis [6,7].
The inherited human diseases cleidocranial dysplasia and fam-
ilial platelet disorder with propensity to acute myeloid leuke-
mia and many cases of acute lymphatic leukemia and acute
myeloid leukemia have been linked to Runt proteins [8,9].
There exists experimental evidence that CBFL is required
for the function of at least one Runt protein in vivo [10].
We have found that amino acids 46^185 of AML1 with a
C72S, C81S double mutation (Runt185) coordinate a Cl3 ion
with high occupancy to one of the putative DNA binding
loops (Fig. 1) (Ba«ckstro«m et al. unpublished). Also Cl3 ions
with lower occupancies were found. The high occupancy Cl3
is coordinated by the NO and NR2 nitrogens of R139, the
mainchain nitrogen of V170 and the oxygen atoms of one
or two water molecules R139 and V170 are strictly conserved
throughout species in Runt proteins. Given that Cl3 binds to
the Runt domain in a region that presumably is involved in
DNA binding we decided to investigate this feature in detail
with NMR spectroscopy. In this paper we have characterized
the Cl3 binding to Runt185 in its free state and when com-
plexed with DNA or amino acids 1^141 of CBFL (CBFL141)
with NMR 35Cl line-broadening measurements. We also ad-
dress the question whether Cl3 regulates the DNA binding of
Runt proteins.
2. Materials and methods
2.1. Protein puri¢cation and NMR sample preparation
Runt185 was puri¢ed following the method outlined in [11]. Expres-
sion of CBFL141 was made following the same protocol as for Runt185
except that a plasmid carrying the dnaY gene [12] was co-transformed
into the Escherichia coli BL21(DE3) cells. Recombinant CBFL141 is
produced at high levels and is completely soluble. Puri¢cation of
CBFL141 was accomplished using Ni/nitrilotriacetic acid agarose,
DEAE Sepharose Cl-6B (Pharmacia Biotech) and Superdex 75 gel
¢ltration (Pharmacia Biotech) columns. NMR samples were prepared
by an additional gel ¢ltration in the appropriate NMR bu¡er.
2.2. NMR spectroscopy
NMR spectra were acquired at 600 MHz proton frequency (58.8
MHz 35Cl frequency) on a Bruker AVANCE spectrometer. The spec-
trometer was equipped with three rf-channels, pulsed ¢eld gradients
and a 5 mm broad band (1H/BB) probe. One-dimensional 35Cl spectra
were acquired with 512 data points, 340^5000 scans, a spectral width
of 1200 Hz and a relaxation delay of 50 ms. NMR spectra were
analyzed with XWIN-NMR.
2.3. Line-broadening assay
The desired quantity in the line-broadening assay is the 35Cl excess
transverse relaxation rate (R2;e). R2;e is de¢ned as the observed R2
minus the R2 of free Cl3, where R2 is equal to Z multiplied with
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the full width at half height of the NMR signal (FWHH). Titration
experiments were done by adding aliquots from 2 or 4 M NaCl stock
solutions to samples containing the desired protein, DNA or com-
plexes thereof. At each experimental point a one-dimensional 35Cl
spectra was acquired and the FWHH was measured. Linear and
non-linear curve ¢tting was accomplished with the program Origin.
3. Results
3.1. Model of a Runt185/DNA complex
Structural homologs of Runt185 were identi¢ed with the
DALI server [13]. One strong structural homolog is STAT-
1. The X-ray structure of STAT-1 has been solved in complex
with an 18 bp duplex DNA [14]. Superposition of the CK trace
of 55 amino acids around the A-B and E-F strands of Runt185
(nomenclature according to [3]) and the corresponding resi-
dues in STAT-1 rendered an RMSD of 2.28 Aî . Fig. 1 shows
Runt185 superimposed on STAT-1. Only the DNA of STAT-1
is shown. In the model, R80 of Runt appears to interact with
the major groove while R139 and R142 interact with the
minor groove of the DNA. These three residues are com-
pletely conserved in Runt domain containing proteins and
their importance in DNA binding and disease have been
shown by mutant analysis [15,16]. These facts support the
model. The Cl3 ion coordinated by R139 and V170 com-
pletely overlaps with a DNA phosphate group in our model
(Fig. 1).
3.2. Cl3 binding model and justi¢cation of assumptions
It is possible to determine the Cl3 dissociation constant for
a protein (Kd;Cl) with 35Cl line-broadening measurements. A
simpli¢ed model for Cl3 binding can be used provided that
the following assumptions can be justi¢ed: (i) the exchange
process is fast on the NMR timescale, (ii) the di¡erence in
chemical shift between free and bound Cl3 is small, (iii) the
amount of free Cl3can be approximated with the total
amount, and (iv) the lineshapes of the broadened lines are
Lorentzian. R2;e may under these circumstances be expressed
by a two site model [17] (Eq. 1) which contains both strong
and weak Cl3 binding sites :
R2;e  niCprKa;ClR2;i1 Ka;ClCCl 
X
j
PjR2;j 1
where ni is the number of strong Cl3 binding sites (ni is equal
to unity in Runt185 as deduced from the crystal structure), Cpr
is the total protein or protein-complex concentration, Ka;Cl is
the association constant for Cl3 binding, R2;i is the 35Cl in-
trinsic relaxation rate at site i, CCl is the total concentration of
Cl3. gjPjR2;j corresponds to any low a⁄nity binding sites and
gives rise to an apparent constant contribution to R2;e. It is
known that a plot of ln(R2;e) versus T31 is ¢rst order with a
positive slope for exchange processes in the fast regime [18].
Fig. 2 shows this plot for a Runt185 sample. The experimental
data could be ¢tted to a straight line with positive slope, hence
we conclude that the exchange process is fast. We could not
detect any change in 35Cl resonance frequency during the
Fig. 1. Model of a Runt185/DNA complex. The side chains of R80,
R139 and R142 are shown in a ball and stick representation. The
Cl3 ion coordinated by V170, R139 and one or two water mole-
cules is represented as a gray sphere.
Fig. 2. Natural logarithm of R2;e plotted against the inverse abso-
lute temperature. The sample contained 28 WM Runt185 with 10
mM NaCl and 3 mM sodium phosphate at pH 6.8. The relaxation
rate was ¢tted to a straight line using the least-squares method.
Fig. 3. Fit of a Lorentzian lineshape with a FWHH of 14.7 Hz
(dotted line) to the observed 35Cl resonance in one of the samples
in a titration of NaCl to Runt185 (solid line). The sample contained
31 WM Runt185, 24 mM NaCl with 3 mM sodium phosphate at pH
6.8 and the spectra was acquired at 291 K.
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titrations within our experimental accuracy showing that the
chemical shift di¡erence between free and bound Cl3 is small.
The total amounts of Cl3 (mM range) in the experiments are
much larger than the protein concentrations (WM range). The
fraction bound Cl3 is thereby low and free Cl3 concentration
can be approximated with the total concentration. All NMR
spectra in our study have resonances with Lorentzian line-
shapes (Fig. 3) which is a prerequisite for fast exchange. To
determine if the gjPjR2;j parameter gives a statistically im-
proved ¢t we carried out F tests [19]. In these tests we com-
pared ¢ts of R2;e to models with and without gjPjR2;j . It turns
out that the model including gjPjR2;j was signi¢cantly im-
proved at the 99% level in all titrations. Our conclusion fol-
lowing the reasoning above is that Eq. 1 is valid for analysis
of R2;e.
3.3. Cl3 binding by Runt185
The experimental results and the curve ¢tted to Eq. 1 of a
NaCl titration to Runt185 is shown in Fig. 4. All ¢tted param-
eters and the M2 value are summarized in Table 1. The quality
of the ¢t is good based on the low M2 value. The dissociation
constant for Cl3 binding to Runt185 is in the order of 34 mM.
R2;i is about 18 000 (s31). Low a⁄nity binding contributes
with a constant o¡set to the binding curve of 2.2 (s31).
3.4. Cl3 binding by a Runt185/DNA complex
It is apparent from our Runt185/DNA model (Fig. 1) that
there exist steric interference between the Cl3 ion bound to
free Runt185 and a DNA phosphate atom in the complex. If
the model is valid, then Runt185 should be disabled to bind
Cl3 in the DNA bound state. To investigate this relationship
we acquired four 35Cl spectra each containing 10 mM NaCl;
the ¢rst on a reference NaCl sample; the second on 20 WM
free Runt185 ; the third after addition of a 14 bp DNA oligo-
mer [11] to a concentration of 30 WM; and a fourth spectrum
was acquired on a sample containing 30 WM of the free DNA.
The reference 35Cl FWHH was measured to 11 Hz. Free
Runt185 has a 35Cl FWHH of 17 Hz. Addition of DNA to
Runt185 induced a decrease in the 35Cl FWHH to 11 Hz (Fig.
5). Also the sample containing free DNA had a FWHH of 11
Hz.
3.5. Cl3 binding by a Runt185/CBFL141 complex
To examine whether CBFL can modulate the Cl3 binding
by Runt we measured R2;e of a 1:1 Runt185/CBFL141 complex
as a function of NaCl concentration. Fig. 4 shows the data
and the ¢t of Eq. 1 which is also summarized in Table 1. The
Kd;Cl of the complex is 56 mM, somewhat higher than the
Kd;Cl for free Runt185. The value of R2;i has increased to
30 000 s31 and the contribution from the low a⁄nity sites
has increased to 5.3 s31. In a separate experiment, we mea-
sured the NaCl dependence of R2;e of a sample containing 60
WM CBFL141 The only e¡ect seen in this experiment was a
constant o¡set in R2;e of 6.4 s31.
Fig. 4. R2;e from two binding experiments plotted as a function of
the NaCl concentration. Squares correspond to 31 WM Runt185.
Circles correspond to a 29 WM 1:1 Runt185/CBFL141 complex. Both
samples contained 3 mM sodium phosphate at pH 6.80. NMR data
were acquired at 291 K. Solid lines are R2;e values calculated with
the ¢tted parameters (Table 1 and Eq. 1).
Table 1
Results of non-linear ¢tting of R2;e to the binding parameters in Eq. 1
High a⁄nity sites Low a⁄nity sites
Ka;Cl (M31) Kd;Cl (mM) R2;i (s31) 4jPjR2;j (s31) M2a
Runt185 29 34 18 000 2.2 0.12
Runt185/CBFL141 18 56 30 000 5.3 0.31
aThe M2 values are de¢ned as M2 =ci(xi3xf )2 where xi are measured values and xf are ¢tted values.
Fig. 5. 35Cl NMR signals acquired at 291 K showing the decrease
in linewidth upon DNA binding by Runt185. The solid line corre-
sponds to a sample containing 20 WM Runt185 and the dashed line
corresponds to a 1:1.5 Runt185/DNA mixture containing 20 WM
protein and 30 WM DNA. Both samples contain NaCl at 10 mM.
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4. Discussion
In this paper we have determined Kd;Cl values of the Runt
domain of the AML1 transcription factor. Cl3 binding by
Runt185 can be described with a two site model containing
low and high a⁄nity binding sites. We have obtained a
Kd;Cl of 34 mM for uncomplexed Runt185. In contrast to
Runt, CBFL141 binds Cl3 unspeci¢cally as it only contains
low a⁄nity sites judged from the NaCl concentration inde-
pendent R2;e value of 6.4 s31. Addition of DNA to Runt185
completely abolished the Cl3 binding (Fig. 5). DNA and Cl3
evidently compete for binding sites in the same region of the
protein surface.
One Cl3 ion bound with high occupancy was detected in
the crystal structure of Runt185 (Ba«ckstro«m et al., unpub-
lished) Our Runt185/DNA model is consistent with overlap-
ping binding sites for DNA and the high occupancy ion. The
fact that association with DNA removes high a⁄nity Cl3
suggests that the high a⁄nity binding in solution is associated
with high occupancy in the crystal structure, as expected. The
low a⁄nity binding class may then be associated with the
lower-occupancy sites as well as with other, even weaker,
binding sites not detected in the crystal structure.
One interesting question is whether CBFL141 a¡ects the
strength of the Cl3 binding by Runt185. NMR measurements
on a Runt185/CBFL141 complex reveal a Kd;Cl value of 56 mM.
As CBFL141 only binds Cl3 weakly we draw the conclusion
that the only strong site in the complex is the Runt185 site. Cl3
binding by Runt185 is obviously about 1.6 times weaker in the
heterodimeric complex compared to the free state. R2;i in-
creases from 18 000 s31 in free Runt185 to 30 000 s31 in the
heterodimeric state. The magnitudes of the R2;i values are on
the order of expected numbers for a protein-bound Cl3 [18].
From a functional point of view it is necessary to consider
the relevance of Kd;Cl values in the 30^60 mM range. Band3,
an abundant integral membrane protein in human erythrocyte
membranes that exchanges interior HCO33 for Cl
3 ions from
outside the membrane, contains Cl3 binding sites with Kd;Cl
values ranging from 65 to 80 mM [20]. Cytoplasmic and nu-
clear Cl3 concentrations in human cells are approximately
equal [21] and span from about 15 to 60 mM [22,23]. The
magnitude of these intracellular Cl3 concentrations and
Kd;Cl values indicates that the strength of Cl3 binding by
AML1 might have functional implications. The possible role
of Cl3 binding by Runt is unknown. We speculate that Cl3
might regulate DNA binding of the Runt domain in a neg-
ative or positive way. Cl3 might act as a competitive inhibitor
to DNA or force the sidechain of R139 to adopt a conforma-
tion that is optimal for DNA binding. Another possibility is
that Cl3 might a¡ect the negative in£uences that N- and C-
terminal sequences exert on the DNA binding of the Runt
domain [11,24]. All scenarios could be consistent with Cl3
being excluded from the DNA bound state. However, our
data do not allow distinction between these or any other pos-
sible functions for Cl3 binding. Whatever the function of Cl3,
we believe that all Runt domain containing proteins bind Cl3
considering that the binding residues R139 and V170 are
strictly conserved.
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